FDA’s overhaul of cosmetics regulation comes with a loophole allowing cancerous hair relaxers on shelves
By Jonathan Sharp In December 2022, the Consolidated Appropriations Act bolstered the FDA’s regulatory abilities to address vital safety issues in the widely-unregulated cosmetics industry. The bill’s subtitle, known as the Modernization of Cosmetics Regulation Act (MoCRA), represents the first significant reform targeting cosmetic products since 1938. While MoCRA is regarded as a belated, yet